ArticleEClinicalMedicine2026

SGLT2 inhibitors and risk of distant metastasis in patients with breast cancer and type 2 diabetes: a target trial emulation with biological plausibility analysis.

Po-Huang Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.